Search

everythinglearnresearchcommunity

for

Search:↓

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Alopesi tedavisinde ilaçlar saç büyümesini teşvik eder ve yeni yaklaşımlar umut vaat eder.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Topical minoxidil improves female pattern hair loss, finasteride not effective, laser devices show mixed results.

Treat pattern hair loss with finasteride and topical minoxidil.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Heat and chemicals improve finasteride delivery to scalp and hair follicles, potentially enhancing treatment for hair loss.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Effective acne management in PCOS includes hormone therapy, metformin, isotretinoin, weight loss, diet, exercise, and personalized treatment plans.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Finasteride and minoxidil are the main effective treatments for hair loss from androgenetic alopecia.

Early diagnosis and treatment can help manage fibrosing alopecia in older women.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.